4-(4-chlorobenzoyl)butanoic acid | 36978-49-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-(4-chlorobenzoyl)butanoic acid
• 英文别名: 5-(4-chlorophenyl)-5-oxopentanoic acid；4-(4-chlorobenzoyl)butyric acid
• CAS: 36978-49-1
• 化学式: C₁₁H₁₁ClO₃
• mdl: MFCD01320019
• 分子量: 226.66
• InChiKey: BVLILROMUFYKGH-UHFFFAOYSA-N

物化性质

• 熔点：
  124-129 °C
• 沸点：
  324.6°C (rough estimate)
• 密度：
  1.2401 (rough estimate)
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.272
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 安全说明：
  S24/25
• 海关编码：
  2918300090
• 危险性防范说明：
  P261,P301+P312,P302+P352,P304+P340,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  存于阴凉干燥处。

SDS

Name:	3-(p-Chlorobenzoyl)-Butyric Acid 98% Material Safety Data Sheet
Synonym:	None Known
CAS:	36978-49-1

Section 1 - Chemical Product MSDS Name:3-(p-Chlorobenzoyl)-Butyric Acid 98% Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
36978-49-1	3-(p-Chlorobenzoyl)-Butyric Acid	98%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam. Use agent most appropriate to extinguish fire.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 36978-49-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: beige
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 140 - 142 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: ClC6H4C(O)(CH2)3COOH
Molecular Weight: 226.5282

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 36978-49-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-(p-Chlorobenzoyl)-Butyric Acid - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 36978-49-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 36978-49-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 36978-49-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(4-chlorobenzoyl)butanoic acid 在 hydrido(phosphonite)cobalt(I) 、 频那醇硼烷 作用下， 以 2-甲基四氢呋喃 为溶剂， 反应 16.0h， 生成 5-(4-chlorophenyl)-5-hydroxypentanoic acid
  参考文献：
  名称：

  用光控制催化硼氢化反应的化学选择性

  摘要：

  据报道，使用明确的氢化钴催化剂对酮酸进行光控、化学选择性硼氢化。可以实现优异的选择性，酸在黑暗中反应，酮在光下反应。这种方法可以进一步扩展到其他功能组。

  DOI：

  10.1002/anie.202114482
• 作为产物：
  描述：

  2-(4-氯苯基)环戊酮 在 水 、 copper(II) bis(trifluoromethanesulfonate) 作用下， 以 乙腈 为溶剂， 反应 48.0h， 以86%的产率得到4-(4-chlorobenzoyl)butanoic acid
  参考文献：
  名称：

  可见光驱动、铜催化的环烷酮需氧氧化裂解

  摘要：

  已经提出了一种可见光驱动的、铜催化的环烷酮有氧氧化裂解。具有不同环大小和各种α-取代基的各种环烷酮反应良好，以中等至良好的产率得到远端酮酸或二羧酸。

  DOI：

  10.1021/acs.joc.1c00708

文献信息

• Piperazine and homopiperazine compounds
  申请人：Millennium Pharmaceuticals, Inc.

  公开号：US20030153556A1

  公开（公告）日：2003-08-14

  Compounds are provided having a piperazine or homopiperazine ring which are useful in the treatment of thrombosis.

  提供了具有哌嗪或同源哌嗪环的化合物，这些化合物在治疗血栓症方面很有用。
• Electrocatalytic Dehydrogenative Esterification of Aliphatic Carboxylic Acids: Access to Bioactive Lactones
  作者：Sheng Zhang、Fei Lian、Mengyu Xue、Tengteng Qin、Lijun Li、Xu Zhang、Kun Xu

  DOI：10.1021/acs.orglett.7b03333

  日期：2017.12.15

  A scalable and efficient electrocatalytic dehydrogenative esterification is reported. With an indirect electrolysis strategy, both intra- and intermolecular-type reactions were amenable to this practical method. With n-Bu4NI as the catalyst, undesired decarboxylation and Baeyer–Villiger oxidation were suppressed. More importantly, this novel method provided reliable and direct access to the natural

  据报道可扩展且有效的电催化脱氢酯化。通过间接电解策略，分子内和分子间反应都适合该实用方法。使用n -Bu 4 NI作为催化剂，可以抑制不希望的脱羧和Baeyer-Villiger氧化。更重要的是，这种新颖的方法可提供以克为单位的对天然产物胞嘧啶酮A的可靠，直接的获取。
• Aryl Boronic Acid Catalysed Dehydrative Substitution of Benzylic Alcohols for C−O Bond Formation
  作者：Susana Estopiñá‐Durán、Liam J. Donnelly、Euan B. Mclean、Bryony M. Hockin、Alexandra M. Z. Slawin、James E. Taylor

  DOI：10.1002/chem.201806057

  日期：2019.3.12

  substitution of benzylic alcohols with a second alcohol to form new C−O bonds. This method has been applied to the intermolecular substitution of benzylic alcohols to form symmetrical ethers, intramolecular cyclisations of diols to form aryl‐substituted tetrahydrofuran and tetrahydropyran derivatives, and intermolecular crossed‐etherification reactions between two different alcohols. Mechanistic control

  五氟苯基硼酸和草酸的组合催化苄醇与第二种醇的脱水取代，形成新的C-O键。该方法已应用于苯甲醇的分子间取代以形成对称醚，二醇的分子内环化以形成芳基取代的四氢呋喃和四氢吡喃衍生物，以及两种不同醇之间的分子间交叉醚化反应。机械控制实验已经确定了在芳基硼酸和草酸之间形成的潜在催化中间体。
• Facile aerobic photooxidative oxylactonization of oxocarboxylic acids in fluorous solvents
  作者：Norihiro Tada、Lei Cui、Takafumi Ishigami、Kazunori Ban、Tsuyoshi Miura、Bunji Uno、Akichika Itoh

  DOI：10.1039/c2gc36238d

  日期：——

  We developed efficient aerobic photooxidative oxylactonizations of oxocarboxylic acids promoted by trifluoroacetic anhydride with molecular oxygen as the terminal oxidant in the fluorous solvent FC-72.

  我们开发了一种高效的有氧光氧化羟基内酯化反应，以三氟醋酸酐为促进剂，分子氧为终端氧化剂，在氟碳溶剂FC-72中进行对氧代羧酸的反应。
• Iridium-Catalyzed Asymmetric Hydrogenation of γ- and δ-Ketoacids for Enantioselective Synthesis of γ- and δ-Lactones
  作者：Yun-Yu Hua、Huai-Yu Bin、Tao Wei、Hou-An Cheng、Zu-Peng Lin、Xing-Feng Fu、Yuan-Qiang Li、Jian-Hua Xie、Pu-Cha Yan、Qi-Lin Zhou

  DOI：10.1021/acs.orglett.9b04253

  日期：2020.2.7

  A highly efficient asymmetric hydrogenation of γ- and δ-ketoacids was developed by using a chiral spiro iridium catalyst (S)-1a, affording the optically active γ- and δ-hydroxy acids/lactones in high yields with excellent enantioselectivities (up to >99% ee) and turnover numbers (TON up to 100000). This protocol provides an efficient and practical method for enantioselective synthesis of Ezetimibe

  通过使用手性螺铱催化剂（S）-1a开发了高效的不对称氢化γ-和δ-酮酸，以高收率提供了光学活性的γ-和δ-羟基酸/内酯，对映选择性极好（高达> 99％ee）和营业额数字（TON最高为100000）。该协议为依泽替米贝的对映选择性合成提供了一种有效而实用的方法。